REVDEX Trademark

Trademark Overview

On Wednesday, January 30, 2019, a trademark application was filed for REVDEX with the United States Patent and Trademark Office. The USPTO has given the REVDEX trademark a serial number of 88282416. The federal status of this trademark filing is REGISTERED as of Tuesday, February 16, 2021. This trademark is owned by Celgene Corporation. The REVDEX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
revdex

General Information

Serial Number88282416
Word MarkREVDEX
Filing DateWednesday, January 30, 2019
Status700 - REGISTERED
Status DateTuesday, February 16, 2021
Registration Number6269159
Registration DateTuesday, February 16, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 22, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 16, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, December 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 27, 2020SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, April 8, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 1, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, March 7, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 7, 2019LETTER OF SUSPENSION E-MAILED
Thursday, March 7, 2019SUSPENSION LETTER WRITTEN
Thursday, March 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 4, 2019ASSIGNED TO LIE
Wednesday, February 27, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 26, 2019NON-FINAL ACTION E-MAILED
Tuesday, February 26, 2019NON-FINAL ACTION WRITTEN
Monday, February 25, 2019ASSIGNED TO EXAMINER
Friday, February 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 2, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

revdex pharmaceutical preparations immune system modulate inhibitory namely cytokine drugs